<?xml version="1.0" encoding="UTF-8"?>
<p id="p0120">On the basis of citation frequency, the most cited plant species by the informants to treat any cancer type were respectively 
 <italic>Nigella sativa</italic> L. (FC = 131), 
 <italic>Aristolochia longa</italic> L. (FC = 118), 
 <italic>Berberis vulgaris</italic> L. (CF = 111), 
 <italic>Curcuma longa</italic> L. (CF = 107), 
 <italic>Trigonella foenum-graecum</italic> L. (FC = 102), Citrus limon (L.) Osbeck (CF = 97), 
 <italic>Artemisia herba-alba</italic> Asso (CF = 92), 
 <italic>Ephedra alata</italic> Decne (CF = 91), 
 <italic>Atriplex halimus</italic> L. and 
 <italic>Allium cepa</italic> L. (CF = 90). Furthermore, on the basis of use reports and use value indices for each species, Nigella sativa L. was the most reported/important plant species (UR = 152, UV = 0.54) followed by 
 <italic>Aristolochia longa</italic> L. (UR = 144, UV = 0.51), 
 <italic>Berberis vulgaris</italic> L. (UR = 142, UV = 0.51), 
 <italic>Curcuma longa</italic> (UR = 121, UV = 0.43), 
 <italic>Trigonella foenum-graecum</italic> L. (UR = 119, UV = 0.43), Citrus limon Decne (UR = 120, UV = 0.43), 
 <italic>Artemisia herba-alba</italic> Asso (UR = 115, UV = 0.41) and Allium cepa L. (UR = 107, UV = 0.38). However, the less cited plant species with the lowest use reports were Stipa tenacissima L. and Phaseolus vulgaris L. (CF = 3, UR = 3, UV = 0.01) (
 <xref rid="t0010" ref-type="table">Table 2</xref>).
</p>
